Using the industry peer median EV/Revenue multiple (trailing + forward), Nano-X Imaging Ltd. (NNOX) has a fair value of $1.19 based on 10 comparable companies in the Medical - Devices industry.
USD in millions except Fair Price. Subject company highlighted.
| Mkt Cap ($M) | Trailing EV/Revenue | Forward EV/Revenue | |
|---|---|---|---|
| Nano-X Imaging Ltd.NNOX | 112 | 5.4x | 5.3x |
| Perspective Therapeutics, Inc. | 277 | 188.5x | — |
| Profound Medical Corp. | 217 | 8.6x | 4.6x |
| Inogen, Inc. | 192 | 0.3x | 0.3x |
| TriSalus Life Sciences, Inc. | 169 | 4.1x | 3.1x |
| SANUWAVE Health, Inc. | 143 | 3.5x | 2.4x |
| Quanterix Corporation | 129 | 1.0x | 0.8x |
| Health Catalyst, Inc. | 112 | 0.7x | 0.8x |
| MaxCyte, Inc. | 90 | 2.7x | 2.5x |
| Solana Company | 89 | 13.7x | 175.6x |
| Outset Medical, Inc. | 68 | 1.2x | 1.1x |
| Industry Median | 3.1x | 2.4x | |
| (*) Revenue | 13 | 13 | |
| = Enterprise Value | 40 | 31 | |
| (-) Net Debt | -41 | -41 | |
| Equity Value | 81 | 73 | |
| (/) Outstanding shares | 65 | 65 | |
| Fair Price | $1 | $1 | |
Disclaimer: Sweet Value Lab provides estimated intrinsic values for informational purposes only. This is not financial advice. All models rely on assumptions that may not reflect future performance. Always do your own research before making investment decisions.